Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA), sold 605 shares at $32.99 ($20K) on 2024-03-04, disclosed to the SEC on 2024-03-05.
Open-market sale of $20k NTLA by EVP, Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2025-07-03 | $10K | — | Filing → |
| NTLA | SELL | 2025-03-04 | $6K | — | Filing → |
| NTLA | SELL | 2025-01-06 | $187K | — | Filing → |